Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYInfectious disease reports

Genotype Distribution Characteristics and Short-Term Follow-Up of HPV Infection Among Male Outpatients in Wenzhou, China.

  1. 1Department of Clinical Laboratory, Wenzhou People's Hospital, Wenzhou 325041, China.
  2. 2Department of Reproductive Medicine, Wenzhou Maternal and Child Health Hospital, Wenzhou 325000, China.
  3. 3Department of Disease Control and Prevention, Wenzhou Lucheng Center for Disease Control and Prevention, Wenzhou 325007, China.

Abstract

Objective

The aim of this study was to investigate the genotype distribution, co-infection patterns, and disease-specific characteristics of human papillomavirus (HPV) infection among male outpatients in Wenzhou, China.Methods

A total of 1934 male outpatients who underwent HPV genotyping at Wenzhou People's Hospital and Wenzhou Maternal and Child Health Hospital between April 2023 and March 2026 were enrolled. Baseline infection status, clinical manifestations, genotype co-infection patterns, and six-month follow-up outcomes were analyzed.Results

The overall HPV positivity rate was 39.14%. HPV52 was the most prevalent high-risk genotype (13.61%, 95% CI: 11.12-16.43%), most frequently co-detected with HPV51 and HPV58, whereas HPV6 dominated low-risk genotypes (40.16%, 95% CI: 36.69-43.66%). HPV positivity differed significantly across disease groups (p < 0.001), with the highest rate observed in mucocutaneous lesions (58.07%, 95% CI: 53.89-62.18%). Single-genotype infection predominated (73.71%, 95% CI: 70.58-76.85%). Of 757 HPV-positive patients, 403 (53.24%) completed six-month follow-up, and their rates of complete clearance, isolated persistence, incident-only genotype, and superinfection were 52.61%, 28.04%, 13.40%, and 5.96%, respectively.Conclusions

These findings underscore the need for male-specific HPV screening strategies, targeted health education for high-risk populations, and age-stratified individualized follow-up protocols. Such regional epidemiological evidence may help optimize local prevention, intervention, and clinical management of HPV-associated disorders in men.

Related

  1. Prevalence and genotype distribution of human papillomavirus among 15,224 gynecological outpatients in Xuzhou, China, during 2023-2025.
    Shuo Chai, Lulu Hu, Wenting Fan +5
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  2. Prevalence and genotype distribution of norovirus and rotavirus among children under five with diarrheal infection in lower-middle-income countries after Rotavirus vaccine introduction: A systematic review and meta-analysis
    Firayad Ayele, Tesfaye Assebe, Miheret Mandefro +2
    PLOS OnePeer-reviewedCC BY 4.0Full textMicrobiologyStatisticsPLOS
  3. Association of current HbA1c with concurrent multiorgan screening abnormalities and the incremental value of routine clinical characteristics in type 2 diabetes: a single-center cross-sectional study in Wenzhou, China.
    Chengcheng Ye, Huahua Peng, Xinxin Wang +1
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  4. Epidemiological Characteristics of Pediatric Drug Poisoning in Wenzhou, China in 2017-2024.
    Chengjie Chen, Huating Xie, Keke Chen +3
    Journal of epidemiology and global healthPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ
  5. High Seroprevalence of Herpes Simplex Virus Type 2 Infection in French Human Immunodeficiency Virus Type 1-Infected Outpatients
    Laurent Andréoletti, Emmanuel Piednoir, Jérôme Legoff +9
    Journal of Clinical MicrobiologyPeer-reviewedLicence not stated14 citedEpidemiology & public healthHAL
BibTeX
@article{dai2026genotype,
  title = {{Genotype Distribution Characteristics and Short-Term Follow-Up of HPV Infection Among Male Outpatients in Wenzhou, China.}},
  author = {Xianning Dai and Chenhui Zhang and Xi Xu and Kai Xu and Zitong Qian and Xi Chen},
  journal = {Infectious disease reports},
  year = {2026},
  month = oct,
  doi = {10.3390/idr18050116},
  url = {https://europepmc.org/article/MED/42930507},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Genotype Distribution Characteristics and Short-Term Follow-Up of HPV Infection Among Male Outpatients in Wenzhou, China.
AU  - Xianning Dai
AU  - Chenhui Zhang
AU  - Xi Xu
AU  - Kai Xu
AU  - Zitong Qian
AU  - Xi Chen
PY  - 2026
DA  - 2026/10/08
JO  - Infectious disease reports
DO  - 10.3390/idr18050116
UR  - https://europepmc.org/article/MED/42930507
AB  - Objective  The aim of this study was to investigate the genotype distribution, co-infection patterns, and disease-specific characteristics of human papillomavirus (HPV) infection among male outpatients in Wenzhou, China.Methods  A total of 1934 male outpatients who underwent HPV genotyping at Wenzhou People's Hospital and Wenzhou Maternal and Child Health Hospital between April 2023 and March 2026 were enrolled. Baseline infection status, clinical manifestations, genotype co-infection patterns, and six-month follow-up outcomes were analyzed.Results  The overall HPV positivity rate was 39.14%. HPV52 was the most prevalent high-risk genotype (13.61%, 95% CI: 11.12-16.43%), most frequently co-detected with HPV51 and HPV58, whereas HPV6 dominated low-risk genotypes (40.16%, 95% CI: 36.69-43.66%). HPV positivity differed significantly across disease groups (p < 0.001), with the highest rate observed in mucocutaneous lesions (58.07%, 95% CI: 53.89-62.18%). Single-genotype infection predominated (73.71%, 95% CI: 70.58-76.85%). Of 757 HPV-positive patients, 403 (53.24%) completed six-month follow-up, and their rates of complete clearance, isolated persistence, incident-only genotype, and superinfection were 52.61%, 28.04%, 13.40%, and 5.96%, respectively.Conclusions  These findings underscore the need for male-specific HPV screening strategies, targeted health education for high-risk populations, and age-stratified individualized follow-up protocols. Such regional epidemiological evidence may help optimize local prevention, intervention, and clinical management of HPV-associated disorders in men.
SN  - 2036-7430
SN  - 2036-7449
ER  -